Identification of a therapeutic interfering particle—A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance
Sonali Chaturvedi, Gustavo Vasen, Michael Pablo, Xinyue Chen, Nathan Beutler, Arjun J. Kumar, Elizabeth J. Tanner, Sylvia E. Moortgat Illouz, Donna Rahgoshay, John Burnett, Leo Holguin, Peiyi Chen, Blaise Ndjamen, Mélanie Ott, Robert Rodick, Thomas F. Rogers, Davey M. Smith, Leor S. Weinberger
Topics & Concepts
BiologyVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakDrug resistanceIdentification (biology)Resistance (ecology)MicrobiologyDiseaseInfectious disease (medical specialty)Internal medicineOutbreakBotanyMedicineEcologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing